Cite
Evaluation of clinical significance of endoglin expression during breast cancer and its correlation with ER and PCNA.
MLA
Guo, J. L., et al. “Evaluation of Clinical Significance of Endoglin Expression during Breast Cancer and Its Correlation with ER and PCNA.” European Review for Medical & Pharmacological Sciences, vol. 21, no. 23, Dec. 2017, pp. 5402–07. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=126888166&authtype=sso&custid=ns315887.
APA
Guo, J.-L., Gu, S.-Q., Li, Y., & Zhang, X.-Y. (2017). Evaluation of clinical significance of endoglin expression during breast cancer and its correlation with ER and PCNA. European Review for Medical & Pharmacological Sciences, 21(23), 5402–5407.
Chicago
Guo, J.-L., S.-Q. Gu, Y. Li, and X.-Y. Zhang. 2017. “Evaluation of Clinical Significance of Endoglin Expression during Breast Cancer and Its Correlation with ER and PCNA.” European Review for Medical & Pharmacological Sciences 21 (23): 5402–7. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=126888166&authtype=sso&custid=ns315887.